EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis

Xing Liu, Xinhui Peng, Shuai Cen, Cuiting Yang, Zhijie Ma, Xinyuan Shi

Frontiers in Pharmacology · 22.02.2023 · 14

DOI: 10.3389/fphar.2023.1129662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 22.02.2023. Verfasst von Xing Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer is a common gastrointestinal tract malignancy. Currently, the therapeutic strategies for pancreatic cancers include surgery, radiotherapy, and chemotherapy; however, the surgical procedure is invasive, and the overall curative outcomes are poor. Furthermore, pancreatic cancers are usually asymptomatic during early stages and have a high degree of malignancy, along with a high rate of recurrence and metastasis, thereby increasing the risk of mortality. Studies have shown that ferroptosis regulates cell proliferation and tumour growth and reduces drug resistance. Hence, ferroptosis could play a role in preventing and treating cancers. Wogonin is a flavonoid with anticancer activity against various cancers, including pancreatic cancer. It is extracted from the root of Scutellaria baicalensis Georgi . In this study, we show that wogonin inhibits the survival and proliferation of human pancreatic cancer cell lines and induces cell death. We performed RNA-sequencing and analysed the differentially expressed gene and potential molecular mechanism to determine if wogonin reduced cell survival via ferroptosis. Our results showed that wogonin upregulates the levels of Fe 2+ , lipid peroxidation and superoxide and decreases the protein expression levels of ferroptosis suppressor genes, and downregulates level of glutathione in pancreatic cancer cells. In addition, ferroptosis inhibitors rescue the ferroptosis-related events induced by wogonin, thereby confirming the role of ferroptosis. A significant increase in ferroptosis-related events was observed after treatment with both wogonin and ferroptosis inducer. These results show that wogonin could significantly reduces pancreatic cancer cell proliferation and induce ferroptosis via the Nrf2/GPX4 axis. Therefore, wogonin could be potentially used for treating patients with pancreatic cancer.

Schlagwörter

Stichwörter der Autor:innen

Nrf2ferroptosislipid peroxidationpancreatic cancerwogonin

Autor:innen und Institutionen

  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
  • Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • School of Life Science, Beijing University of Chinese Medicine, Beijing, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, X., Peng, X., Cen, S., Yang, C., Ma, Z., & Shi, X. (2023). Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1129662

Vancouver

Liu X, Peng X, Cen S, Yang C, Ma Z, Shi X. Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1129662

BibTeX
@article{Liu2023,
  author = {Liu, Xing and Peng, Xinhui and Cen, Shuai and Yang, Cuiting and Ma, Zhijie and Shi, Xinyuan},
  title = {Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1129662}
}
Kostenlos starten →